{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T16:34:22Z","timestamp":1793982862464,"version":"4.8.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["AARF-23-1145318"],"award-info":[{"award-number":["AARF-23-1145318"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["AARF-22-974065"],"award-info":[{"award-number":["AARF-22-974065"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["AARG-20-683875"],"award-info":[{"award-number":["AARG-20-683875"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005339","name":"American Academy of Neurology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005331","name":"American Brain Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003607","name":"Association for Frontotemporal Degeneration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003607","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["K23AG061253"],"award-info":[{"award-number":["K23AG061253"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG032289"],"award-info":[{"award-number":["R01AG032289"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["AG019724"],"award-info":[{"award-number":["AG019724"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["P30 AG062422"],"award-info":[{"award-number":["P30 AG062422"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["K23AG073514"],"award-info":[{"award-number":["K23AG073514"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["AG016976"],"award-info":[{"award-number":["AG016976"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["AG058233"],"award-info":[{"award-number":["AG058233"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["U19AG063911"],"award-info":[{"award-number":["U19AG063911"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["U01AG045390"],"award-info":[{"award-number":["U01AG045390"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["U19AG063911"],"award-info":[{"award-number":["U19AG063911"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["U01AG045390"],"award-info":[{"award-number":["U01AG045390"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["AG032306"],"award-info":[{"award-number":["AG032306"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["K24AG045333"],"award-info":[{"award-number":["K24AG045333"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["K23AG059888"],"award-info":[{"award-number":["K23AG059888"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["U19AG063911"],"award-info":[{"award-number":["U19AG063911"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["AG038791"],"award-info":[{"award-number":["AG038791"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001167","name":"Larry L. Hillblom Foundation","doi-asserted-by":"publisher","award":["2018-A-025-FEL"],"award-info":[{"award-number":["2018-A-025-FEL"]}],"id":[{"id":"10.13039\/100001167","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001167","name":"Larry L. Hillblom Foundation","doi-asserted-by":"publisher","award":["2018-A-006-NET"],"award-info":[{"award-number":["2018-A-006-NET"]}],"id":[{"id":"10.13039\/100001167","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2022-00775"],"award-info":[{"award-number":["2022-00775"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004063","name":"Knut och Alice Wallenbergs Stiftelse","doi-asserted-by":"publisher","award":["2022-0231"],"award-info":[{"award-number":["2022-0231"]}],"id":[{"id":"10.13039\/501100004063","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003792","name":"Hj\u00e4rnfonden","doi-asserted-by":"publisher","award":["FO2021-0293"],"award-info":[{"award-number":["FO2021-0293"]}],"id":[{"id":"10.13039\/501100003792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008444","name":"Swedish Parkinson's Disease Association | Parkinsonfonden","doi-asserted-by":"publisher","award":["1412\/22"],"award-info":[{"award-number":["1412\/22"]}],"id":[{"id":"10.13039\/100008444","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007625","name":"Cure Alzheimer's Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["U54NS092089"],"award-info":[{"award-number":["U54NS092089"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["U54NS092089"],"award-info":[{"award-number":["U54NS092089"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["U54NS092089"],"award-info":[{"award-number":["U54NS092089"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Aging"],"DOI":"10.1038\/s43587-025-00878-2","type":"journal-article","created":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T05:02:12Z","timestamp":1747371732000},"page":"1143-1158","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Large-scale network analysis of the cerebrospinal fluid proteome identifies molecular signatures of frontotemporal lobar degeneration"],"prefix":"10.1038","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1351-6183","authenticated-orcid":false,"given":"Rowan","family":"Saloner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3903-9805","authenticated-orcid":false,"given":"Adam M.","family":"Staffaroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2947-7606","authenticated-orcid":false,"given":"Eric B.","family":"Dammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0604-2944","authenticated-orcid":false,"given":"Erik C. B.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily W.","family":"Paolillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Wise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3776-1685","authenticated-orcid":false,"given":"Hilary W.","family":"Heuer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4086-9598","authenticated-orcid":false,"given":"Leah K.","family":"Forsberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Argentina","family":"Lario-Lago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia D.","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6394-9940","authenticated-orcid":false,"given":"Jacob W.","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9717-0820","authenticated-orcid":false,"given":"Alexander F.","family":"Santillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8467-7286","authenticated-orcid":false,"given":"Oskar","family":"Hansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel H.","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce L.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7222-9160","authenticated-orcid":false,"given":"Joseph","family":"Loureiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3917-0181","authenticated-orcid":false,"given":"Rajeev","family":"Sivasankaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen A.","family":"Worringer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4507-624X","authenticated-orcid":false,"given":"Nicholas T.","family":"Seyfried","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7274-2634","authenticated-orcid":false,"given":"Jennifer S.","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3570-9143","authenticated-orcid":false,"given":"Salvatore","family":"Spina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6809-0618","authenticated-orcid":false,"given":"Lea T.","family":"Grinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1410-2027","authenticated-orcid":false,"given":"William W.","family":"Seeley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8304-6711","authenticated-orcid":false,"given":"Lawren","family":"VandeVrede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Ljubenkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6875-4242","authenticated-orcid":false,"given":"Ece","family":"Bayram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Bozoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0543-0228","authenticated-orcid":false,"given":"Danielle","family":"Brushaber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciaran M.","family":"Considine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5133-5538","authenticated-orcid":false,"given":"Gregory S.","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5958-3445","authenticated-orcid":false,"given":"Bradford C.","family":"Dickerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7396-1633","authenticated-orcid":false,"given":"Kimiko","family":"Domoto-Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelley","family":"Faber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6195-3241","authenticated-orcid":false,"given":"Douglas R.","family":"Galasko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7335-2627","authenticated-orcid":false,"given":"Tania","family":"Gendron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2896-3450","authenticated-orcid":false,"given":"Daniel H.","family":"Geschwind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6680-6731","authenticated-orcid":false,"given":"Nupur","family":"Ghoshal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neill","family":"Graff-Radford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chadwick M.","family":"Hales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9703-2265","authenticated-orcid":false,"given":"Lawrence S.","family":"Honig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8017-0856","authenticated-orcid":false,"given":"Ging-Yuek R.","family":"Hsiung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward D.","family":"Huey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Kornak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Kremers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1163-5584","authenticated-orcid":false,"given":"Maria I.","family":"Lapid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzee E.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3485-3445","authenticated-orcid":false,"given":"Irene","family":"Litvan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7581-6405","authenticated-orcid":false,"given":"Corey T.","family":"McMillan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6441-7989","authenticated-orcid":false,"given":"Mario F.","family":"Mendez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toji","family":"Miyagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6427-7485","authenticated-orcid":false,"given":"Alexander","family":"Pantelyat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4467-7406","authenticated-orcid":false,"given":"Belen","family":"Pascual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Masdeu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry L.","family":"Paulson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard","family":"Petrucelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1760-1286","authenticated-orcid":false,"given":"Peter","family":"Pressman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Rademakers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliana Marisa","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katya","family":"Rascovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1810-9763","authenticated-orcid":false,"given":"Erik D.","family":"Roberson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo","family":"Savica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1857-928X","authenticated-orcid":false,"given":"Allison","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Campbell","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5944-8497","authenticated-orcid":false,"given":"M. Carmela","family":"Tartaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9645-2615","authenticated-orcid":false,"given":"Marijne","family":"Vandebergh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4153-8187","authenticated-orcid":false,"given":"Brad F.","family":"Boeve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howie J.","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio C.","family":"Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam L.","family":"Boxer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlin B.","family":"Casaletto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the ALLFTD Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,16]]},"reference":[{"key":"878_CR1","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1016\/S0140-6736(15)00461-4","volume":"386","author":"J Bang","year":"2015","unstructured":"Bang, J., Spina, S. & Miller, B. L. Frontotemporal dementia. Lancet 386, 1672\u20131682 (2015).","journal-title":"Lancet"},{"key":"878_CR2","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s12031-011-9538-y","volume":"45","author":"DS Knopman","year":"2011","unstructured":"Knopman, D. S. & Roberts, R. O. Estimating the number of persons with frontotemporal lobar degeneration in the US population. J. Mol. Neurosci. 45, 330\u2013335 (2011).","journal-title":"J. Mol. Neurosci."},{"key":"878_CR3","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/jnc.13588","volume":"138","author":"IRA Mackenzie","year":"2016","unstructured":"Mackenzie, I. R. A. & Neumann, M. Molecular neuropathology of frontotemporal dementia: insights into disease mechanisms from postmortem studies. J. Neurochem. 138, 54\u201370 (2016).","journal-title":"J. Neurochem."},{"key":"878_CR4","doi-asserted-by":"publisher","first-page":"e2296","DOI":"10.1212\/WNL.0000000000011848","volume":"96","author":"JC Rojas","year":"2021","unstructured":"Rojas, J. C. et al. Plasma neurofilament light for prediction of disease progression in familial frontotemporal lobar degeneration. Neurology 96, e2296\u2013e2312 (2021).","journal-title":"Neurology"},{"key":"878_CR5","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/alz.12004","volume":"16","author":"HJ Rosen","year":"2020","unstructured":"Rosen, H. J., Boeve, B. F. & Boxer, A. L. Tracking disease progression in familial and sporadic frontotemporal lobar degeneration: recent findings from ARTFL and LEFFTDS. Alzheimers Dement. 16, 71\u201378 (2020).","journal-title":"Alzheimers Dement."},{"key":"878_CR6","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1002\/alz.12643","volume":"18","author":"M Del Campo","year":"2022","unstructured":"Del Campo, M. et al. New developments of biofluid-based biomarkers for routine diagnosis and disease trajectories in frontotemporal dementia. Alzheimers Dement. 18, 2292\u20132307 (2022).","journal-title":"Alzheimers Dement."},{"key":"878_CR7","doi-asserted-by":"publisher","first-page":"100065","DOI":"10.1016\/j.bionps.2023.100065","volume":"8","author":"A Gifford","year":"2023","unstructured":"Gifford, A., Praschan, N., Newhouse, A. & Chemali, Z. Biomarkers in frontotemporal dementia: current landscape and future directions. Biomark. Neuropsychiatry 8, 100065 (2023).","journal-title":"Biomark. Neuropsychiatry"},{"key":"878_CR8","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jalz.2019.06.4956","volume":"16","author":"AL Boxer","year":"2019","unstructured":"Boxer, A. L. et al. New directions in clinical trials for frontotemporal lobar degeneration: methods and outcome measures. Alzheimers Dement. 16, 131\u2013143 (2019).","journal-title":"Alzheimers Dement."},{"key":"878_CR9","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1007\/s00415-019-09363-4","volume":"266","author":"CV Greaves","year":"2019","unstructured":"Greaves, C. V. & Rohrer, J. D. An update on genetic frontotemporal dementia. J. Neurol. 266, 2075\u20132086 (2019).","journal-title":"J. Neurol."},{"key":"878_CR10","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1038\/s41591-022-01942-9","volume":"28","author":"AM Staffaroni","year":"2022","unstructured":"Staffaroni, A. M. et al. Temporal order of clinical and biomarker changes in familial frontotemporal dementia. Nat. Med. 28, 2194\u20132206 (2022).","journal-title":"Nat. Med."},{"key":"878_CR11","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.neurobiolaging.2019.02.006","volume":"78","author":"R Ferrari","year":"2019","unstructured":"Ferrari, R., Manzoni, C. & Hardy, J. Genetics and molecular mechanisms of frontotemporal lobar degeneration: an update and future avenues. Neurobiol. Aging 78, 98\u2013110 (2019).","journal-title":"Neurobiol. Aging"},{"key":"878_CR12","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/s41582-018-0047-2","volume":"14","author":"R Balendra","year":"2018","unstructured":"Balendra, R. & Isaacs, A. M. C9orf72-mediated ALS and FTD: multiple pathways to disease. Nat. Rev. Neurol. 14, 544\u2013558 (2018).","journal-title":"Nat. Rev. Neurol."},{"key":"878_CR13","doi-asserted-by":"publisher","first-page":"eabb3774","DOI":"10.1126\/scitranslmed.abb3774","volume":"12","author":"CN Cook","year":"2020","unstructured":"Cook, C. N. et al. C9orf72 poly(GR) aggregation induces TDP-43 proteinopathy. Sci. Transl. Med. 12, eabb3774 (2020).","journal-title":"Sci. Transl. Med."},{"key":"878_CR14","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrn.2017.36","volume":"18","author":"AW Kao","year":"2017","unstructured":"Kao, A. W., McKay, A., Singh, P. P., Brunet, A. & Huang, E. J. Progranulin, lysosomal regulation and neurodegenerative disease. Nat. Rev. Neurosci. 18, 325\u2013333 (2017).","journal-title":"Nat. Rev. Neurosci."},{"key":"878_CR15","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s12031-011-9625-0","volume":"45","author":"S Kumar-Singh","year":"2011","unstructured":"Kumar-Singh, S. Progranulin and TDP-43: mechanistic links and future directions. J. Mol. Neurosci. 45, 561\u2013573 (2011).","journal-title":"J. Mol. Neurosci."},{"key":"878_CR16","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1038\/s41374-019-0197-x","volume":"99","author":"KH Strang","year":"2019","unstructured":"Strang, K. H., Golde, T. E. & Giasson, B. I. MAPT mutations, tauopathy, and mechanisms of neurodegeneration. Lab. Invest. 99, 912\u2013928 (2019).","journal-title":"Lab. Invest."},{"key":"878_CR17","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3390\/biom12040505","volume":"12","author":"S Schmidt","year":"2022","unstructured":"Schmidt, S., Holzer, M., Arendt, T., Sonntag, M. & Morawski, M. Tau protein modulates perineuronal extracellular matrix expression in the TauP301L-acan mouse model. Biomolecules 12, 505 (2022).","journal-title":"Biomolecules"},{"key":"878_CR18","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.cell.2021.12.041","volume":"185","author":"TE Tracy","year":"2022","unstructured":"Tracy, T. E. et al. Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration. Cell 185, 712\u2013728.e714 (2022).","journal-title":"Cell"},{"key":"878_CR19","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41386-020-00840-3","volume":"46","author":"S Rayaprolu","year":"2021","unstructured":"Rayaprolu, S. et al. Systems-based proteomics to resolve the biology of Alzheimer\u2019s disease beyond amyloid and tau. Neuropsychopharmacology 46, 98\u2013115 (2021).","journal-title":"Neuropsychopharmacology"},{"key":"878_CR20","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/s41593-021-00999-y","volume":"25","author":"ECB Johnson","year":"2022","unstructured":"Johnson, E. C. B. et al. Large-scale deep multi-layer analysis of Alzheimer\u2019s disease brain reveals strong proteomic disease-related changes not observed at the RNA level. Nat. Neurosci. 25, 213\u2013225 (2022).","journal-title":"Nat. Neurosci."},{"key":"878_CR21","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13195-022-01113-5","volume":"14","author":"EB Dammer","year":"2022","unstructured":"Dammer, E. B. et al. Multi-platform proteomic analysis of Alzheimer\u2019s disease cerebrospinal fluid and plasma reveals network biomarkers associated with proteostasis and the matrisome. Alzheimers Res. Ther. 14, 174 (2022).","journal-title":"Alzheimers Res. Ther."},{"key":"878_CR22","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s41591-020-0815-6","volume":"26","author":"ECB Johnson","year":"2020","unstructured":"Johnson, E. C. B. et al. Large-scale proteomic analysis of Alzheimer\u2019s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation. Nat. Med. 26, 769\u2013780 (2020).","journal-title":"Nat. Med."},{"key":"878_CR23","doi-asserted-by":"publisher","first-page":"100607","DOI":"10.1016\/j.xcrm.2022.100607","volume":"3","author":"TF Gendron","year":"2022","unstructured":"Gendron, T. F. et al. Comprehensive cross-sectional and longitudinal analyses of plasma neurofilament light across FTD spectrum disorders. Cell Rep. Med. 3, 100607 (2022).","journal-title":"Cell Rep. Med."},{"key":"878_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-66090-x","volume":"10","author":"C Delaby","year":"2020","unstructured":"Delaby, C. et al. Differential levels of neurofilament light protein in cerebrospinal fluid in patients with a wide range of neurodegenerative disorders. Sci. Rep. 10, 9161 (2020).","journal-title":"Sci. Rep."},{"key":"878_CR25","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41531-023-00555-4","volume":"9","author":"B Phillips","year":"2023","unstructured":"Phillips, B. et al. Proteome wide association studies of LRRK2 variants identify novel causal and druggable proteins for Parkinson\u2019s disease. npj Parkinsons Dis. 9, 107 (2023).","journal-title":"npj Parkinsons Dis."},{"key":"878_CR26","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1212\/WNL.0000000000002638","volume":"86","author":"IT Coyle-Gilchrist","year":"2016","unstructured":"Coyle-Gilchrist, I. T. et al. Prevalence, characteristics, and survival of frontotemporal lobar degeneration syndromes. Neurology 86, 1736\u20131743 (2016).","journal-title":"Neurology"},{"key":"878_CR27","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adn3504","volume":"16","author":"EB Dammer","year":"2024","unstructured":"Dammer, E. B. et al. Proteomic analysis of Alzheimer\u2019s disease cerebrospinal fluid reveals alterations associated with APOE \u03b54 and atomoxetine treatment. Sci. Transl. Med. 16, eadn3504 (2024).","journal-title":"Sci. Transl. Med."},{"key":"878_CR28","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s00401-024-02706-0","volume":"147","author":"J Rutledge","year":"2024","unstructured":"Rutledge, J. et al. Comprehensive proteomics of CSF, plasma, and urine identify DDC and other biomarkers of early Parkinson\u2019s disease. Acta Neuropathol. 147, 52 (2024).","journal-title":"Acta Neuropathol."},{"key":"878_CR29","doi-asserted-by":"publisher","unstructured":"Trautwig, A. N. et al. Network analysis of the cerebrospinal fluid proteome reveals shared and unique differences between sporadic and familial forms of amyotrophic lateral sclerosis. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2024.02.29.582840 (2024).","DOI":"10.1101\/2024.02.29.582840"},{"key":"878_CR30","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13024-023-00638-z","volume":"18","author":"ES Modeste","year":"2023","unstructured":"Modeste, E. S. et al. Quantitative proteomics of cerebrospinal fluid from African Americans and Caucasians reveals shared and divergent changes in Alzheimer\u2019s disease. Mol. Neurodegener. 18, 48 (2023).","journal-title":"Mol. Neurodegener."},{"key":"878_CR31","doi-asserted-by":"publisher","first-page":"48","DOI":"10.15252\/emmm.201708202","volume":"10","author":"ME Umoh","year":"2018","unstructured":"Umoh, M. E. et al. A proteomic network approach across the ALS-FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain. EMBO Mol. Med. 10, 48\u201362 (2018).","journal-title":"EMBO Mol. Med."},{"key":"878_CR32","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13024-018-0282-4","volume":"13","author":"ECB Johnson","year":"2018","unstructured":"Johnson, E. C. B. et al. Deep proteomic network analysis of Alzheimer\u2019s disease brain reveals alterations in RNA binding proteins and RNA splicing associated with disease. Mol. Neurodegener. 13, 52 (2018).","journal-title":"Mol. Neurodegener."},{"key":"878_CR33","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41583-023-00717-6","volume":"24","author":"D Nikom","year":"2023","unstructured":"Nikom, D. & Zheng, S. Alternative splicing in neurodegenerative disease and the promise of RNA therapies. Nat. Rev. Neurosci. 24, 457\u2013473 (2023).","journal-title":"Nat. Rev. Neurosci."},{"key":"878_CR34","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1016\/j.celrep.2019.04.003","volume":"27","author":"EY Liu","year":"2019","unstructured":"Liu, E. Y. et al. Loss of nuclear TDP-43 is associated with decondensation of LINE retrotransposons. Cell Rep. 27, 1409\u20131421.e1406 (2019).","journal-title":"Cell Rep."},{"key":"878_CR35","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1146\/annurev-pathmechdis-012418-012955","volume":"14","author":"JW Hofmann","year":"2019","unstructured":"Hofmann, J. W., Seeley, W. W. & Huang, E. J. RNA binding proteins and the pathogenesis of frontotemporal lobar degeneration. Annu Rev. Pathol. 14, 469\u2013495 (2019).","journal-title":"Annu Rev. Pathol."},{"key":"878_CR36","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s00401-020-02203-0","volume":"140","author":"A Bampton","year":"2020","unstructured":"Bampton, A., Gittings, L. M., Fratta, P., Lashley, T. & Gatt, A. The role of hnRNPs in frontotemporal dementia and amyotrophic lateral sclerosis. Acta Neuropathol. 140, 599\u2013623 (2020).","journal-title":"Acta Neuropathol."},{"key":"878_CR37","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1093\/brain\/awy062","volume":"141","author":"J-E Deshaies","year":"2018","unstructured":"Deshaies, J.-E. et al. TDP-43 regulates the alternative splicing of hnRNP A1 to yield an aggregation-prone variant in amyotrophic lateral sclerosis. Brain 141, 1320\u20131333 (2018).","journal-title":"Brain"},{"key":"878_CR38","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1177\/10738584231154551","volume":"30","author":"E Lester","year":"2023","unstructured":"Lester, E. & Parker, R. Tau, RNA, and RNA-binding proteins: complex interactions in health and neurodegenerative diseases. Neuroscientist 30, 458\u2013472 (2023).","journal-title":"Neuroscientist"},{"key":"878_CR39","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/s41591-023-02788-5","volume":"30","author":"KE Irwin","year":"2024","unstructured":"Irwin, K. E. et al. A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS\u2013FTD. Nat. Med. 30, 382\u2013393 (2024).","journal-title":"Nat. Med."},{"key":"878_CR40","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1038\/s41591-024-02937-4","volume":"30","author":"M Chatterjee","year":"2024","unstructured":"Chatterjee, M. et al. Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS. Nat. Med. 30, 1771\u20131783 (2024).","journal-title":"Nat. Med."},{"key":"878_CR41","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1212\/WNL.0000000000004569","volume":"89","author":"KB Casaletto","year":"2017","unstructured":"Casaletto, K. B. et al. Neurogranin, a synaptic protein, is associated with memory independent of Alzheimer biomarkers. Neurology 89, 1782\u20131788 (2017).","journal-title":"Neurology"},{"key":"878_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09613-z","volume":"10","author":"AP Wingo","year":"2019","unstructured":"Wingo, A. P. et al. Large-scale proteomic analysis of human brain identifies proteins associated with cognitive trajectory in advanced age. Nat. Commun. 10, 1619 (2019).","journal-title":"Nat. Commun."},{"key":"878_CR43","doi-asserted-by":"publisher","first-page":"117727192095031","DOI":"10.1177\/1177271920950319","volume":"15","author":"E Camporesi","year":"2020","unstructured":"Camporesi, E. et al. Fluid biomarkers for synaptic dysfunction and loss. Biomark. Insights 15, 1177271920950319 (2020).","journal-title":"Biomark. Insights"},{"key":"878_CR44","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/s41582-019-0222-0","volume":"15","author":"RW Paterson","year":"2019","unstructured":"Paterson, R. W. et al. SILK studies\u2014capturing the turnover of proteins linked to neurodegenerative diseases. Nat. Rev. Neurol. 15, 419\u2013427 (2019).","journal-title":"Nat. Rev. Neurol."},{"key":"878_CR45","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3390\/cells10010038","volume":"10","author":"WA Boiten","year":"2020","unstructured":"Boiten, W. A. et al. Pathologically decreased CSF levels of synaptic marker NPTX2 in DLB are correlated with levels of alpha-synuclein and VGF. Cells 10, 38 (2020).","journal-title":"Cells"},{"key":"878_CR46","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1002\/alz.12353","volume":"17","author":"O Libiger","year":"2021","unstructured":"Libiger, O. et al. Longitudinal CSF proteomics identifies NPTX2 as a prognostic biomarker of Alzheimer\u2019s disease. Alzheimers Dement. 17, 1976\u20131987 (2021).","journal-title":"Alzheimers Dement."},{"key":"878_CR47","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1136\/jnnp-2019-322493","volume":"91","author":"EL van der Ende","year":"2020","unstructured":"van der Ende, E. L. et al. Neuronal pentraxin 2: a synapse-derived CSF biomarker in genetic frontotemporal dementia. J. Neurol. Neurosurg. Psychiatry 91, 612\u2013621 (2020).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"878_CR48","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.euroneuro.2012.07.017","volume":"23","author":"L Wei\u00dfflog","year":"2013","unstructured":"Wei\u00dfflog, L. et al. KCNIP4 as a candidate gene for personality disorders and adult ADHD. Eur. Neuropsychopharmacol. 23, 436\u2013447 (2013).","journal-title":"Eur. Neuropsychopharmacol."},{"key":"878_CR49","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1042\/BST0380445","volume":"38","author":"GW Tam","year":"2010","unstructured":"Tam, G. W. et al. Confirmed rare copy number variants implicate novel genes in schizophrenia. Biochem. Soc. Trans. 38, 445\u2013451 (2010).","journal-title":"Biochem. Soc. Trans."},{"key":"878_CR50","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1002\/ana.26738","volume":"94","author":"L Zhang","year":"2023","unstructured":"Zhang, L. et al. Network connectivity alterations across the MAPT mutation clinical spectrum. Ann. Neurol. 94, 632\u2013646 (2023).","journal-title":"Ann. Neurol."},{"key":"878_CR51","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.nicl.2016.12.006","volume":"14","author":"SE Lee","year":"2017","unstructured":"Lee, S. E. et al. Network degeneration and dysfunction in presymptomatic C9ORF72 expansion carriers. Neuroimage Clin. 14, 286\u2013297 (2017).","journal-title":"Neuroimage Clin."},{"key":"878_CR52","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/s41380-021-01384-8","volume":"27","author":"N Huber","year":"2022","unstructured":"Huber, N. et al. Deficient neurotransmitter systems and synaptic function in frontotemporal lobar degeneration\u2014insights into disease mechanisms and current therapeutic approaches. Mol. Psychiatry 27, 1300\u20131309 (2022).","journal-title":"Mol. Psychiatry"},{"key":"878_CR53","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3389\/fncel.2020.00035","volume":"14","author":"PS Hou","year":"2020","unstructured":"Hou, P. S., hAil\u00edn, D., Vogel, T. & Hanashima, C. Transcription and beyond: delineating FOXG1 function in cortical development and disorders. Front. Cell Neurosci. 14, 35 (2020).","journal-title":"Front. Cell Neurosci."},{"key":"878_CR54","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1002\/jcp.25498","volume":"232","author":"PM Pitale","year":"2017","unstructured":"Pitale, P. M., Howse, W. & Gorbatyuk, M. Neuronatin protein in health and disease. J. Cell. Physiol. 232, 477\u2013481 (2017).","journal-title":"J. Cell. Physiol."},{"key":"878_CR55","doi-asserted-by":"publisher","first-page":"11085","DOI":"10.3390\/ijms231911085","volume":"23","author":"P Pint\u00e9r","year":"2022","unstructured":"Pint\u00e9r, P. & Alp\u00e1r, A. The role of extracellular matrix in human neurodegenerative diseases. Int. J. Mol. Sci. 23, 11085 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"878_CR56","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.3390\/ijms21041539","volume":"21","author":"C De Luca","year":"2020","unstructured":"De Luca, C., Colangelo, A. M., Virtuoso, A., Alberghina, L. & Papa, M. Neurons, glia, extracellular matrix and neurovascular unit: a systems biology approach to the complexity of synaptic plasticity in health and disease. Int. J. Mol. Sci. 21, 1539 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"878_CR57","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1038\/s41591-023-02476-4","volume":"29","author":"ECB Johnson","year":"2023","unstructured":"Johnson, E. C. B. et al. Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer\u2019s disease. Nat. Med. 29, 1979\u20131988 (2023).","journal-title":"Nat. Med."},{"key":"878_CR58","doi-asserted-by":"publisher","first-page":"844211","DOI":"10.3389\/fncel.2022.844211","volume":"16","author":"E Moretto","year":"2022","unstructured":"Moretto, E., Stuart, S., Surana, S., Vargas, J. N. S. & Schiavo, G. The role of extracellular matrix components in the spreading of pathological protein aggregates. Front. Cell. Neurosci. 16, 844211 (2022).","journal-title":"Front. Cell. Neurosci."},{"key":"878_CR59","doi-asserted-by":"publisher","first-page":"19855","DOI":"10.1074\/jbc.R114.549295","volume":"289","author":"BB Holmes","year":"2014","unstructured":"Holmes, B. B. & Diamond, M. I. Prion-like properties of Tau protein: the importance of extracellular Tau as a therapeutic target. J. Biol. Chem. 289, 19855\u201319861 (2014).","journal-title":"J. Biol. Chem."},{"key":"878_CR60","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1016\/j.jalz.2019.06.4951","volume":"15","author":"L Shi","year":"2019","unstructured":"Shi, L. et al. Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay. Alzheimers Dement. 15, 1478\u20131488 (2019).","journal-title":"Alzheimers Dement."},{"key":"878_CR61","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1038\/s41593-021-00886-6","volume":"24","author":"C Yang","year":"2021","unstructured":"Yang, C. et al. Genomic atlas of the proteome from brain, CSF and plasma prioritizes proteins implicated in neurological disorders. Nat. Neurosci. 24, 1302\u20131312 (2021).","journal-title":"Nat. Neurosci."},{"key":"878_CR62","doi-asserted-by":"publisher","first-page":"eadm9654","DOI":"10.1126\/scitranslmed.adm9654","volume":"17","author":"A Sogorb-Esteve","year":"2025","unstructured":"Sogorb-Esteve, A. et al. Proteomic analysis reveals distinct cerebrospinal fluid signatures across genetic frontotemporal dementia subtypes. Sci. Transl. Med. 17, eadm9654 (2025).","journal-title":"Sci. Transl. Med."},{"key":"878_CR63","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/alz.12011","volume":"16","author":"EM Ramos","year":"2020","unstructured":"Ramos, E. M. et al. Genetic screening of a large series of North American sporadic and familial frontotemporal dementia cases. Alzheimers Dement. 16, 118\u2013130 (2020).","journal-title":"Alzheimers Dement."},{"key":"878_CR64","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jalz.2019.06.4947","volume":"16","author":"B Boeve","year":"2020","unstructured":"Boeve, B. et al. The longitudinal evaluation of familial frontotemporal dementia subjects protocol: framework and methodology. Alzheimers Dement. 16, 22\u201336 (2020).","journal-title":"Alzheimers Dement."},{"key":"878_CR65","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.jalz.2010.12.006","volume":"7","author":"DS Knopman","year":"2011","unstructured":"Knopman, D. S., Weintraub, S. & Pankratz, V. S. Language and behavior domains enhance the value of the clinical dementia rating scale. Alzheimers Dement. 7, 293\u2013299 (2011).","journal-title":"Alzheimers Dement."},{"key":"878_CR66","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1093\/brain\/awn234","volume":"131","author":"DS Knopman","year":"2008","unstructured":"Knopman, D. S. et al. Development of methodology for conducting clinical trials in frontotemporal lobar degeneration. Brain 131, 2957\u20132968 (2008).","journal-title":"Brain"},{"key":"878_CR67","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/alz.12033","volume":"16","author":"T Miyagawa","year":"2020","unstructured":"Miyagawa, T. et al. Utility of the global CDR plus NACC FTLD rating and development of scoring rules: data from the ARTFL\/LEFFTDS Consortium. Alzheimers Dement. 16, 106\u2013117 (2020).","journal-title":"Alzheimers Dement."},{"key":"878_CR68","doi-asserted-by":"publisher","first-page":"e201","DOI":"10.1038\/mtna.2014.49","volume":"3","author":"JC Rohloff","year":"2014","unstructured":"Rohloff, J. C. et al. Nucleic acid ligands with protein-like side chains: modified aptamers and their use as diagnostic and therapeutic agents. Mol. Ther. Nucleic Acids 3, e201 (2014).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"878_CR69","doi-asserted-by":"publisher","first-page":"e15004","DOI":"10.1371\/journal.pone.0015004","volume":"5","author":"L Gold","year":"2010","unstructured":"Gold, L. et al. Aptamer-based multiplexed proteomic technology for biomarker discovery. PLoS ONE 5, e15004 (2010).","journal-title":"PLoS ONE"},{"key":"878_CR70","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder, P. & Horvath, S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 9, 559 (2008).","journal-title":"BMC Bioinformatics"},{"key":"878_CR71","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13024-024-00749-1","volume":"19","author":"A Shantaraman","year":"2024","unstructured":"Shantaraman, A. et al. Network proteomics of the Lewy body dementia brain reveals presynaptic signatures distinct from Alzheimer\u2019s disease. Mol. Neurodegener. 19, 60 (2024).","journal-title":"Mol. Neurodegener."},{"key":"878_CR72","doi-asserted-by":"publisher","first-page":"e61505","DOI":"10.1371\/journal.pone.0061505","volume":"8","author":"P Langfelder","year":"2013","unstructured":"Langfelder, P., Mischel, P. S. & Horvath, S. When is hub gene selection better than standard meta-analysis? PLoS ONE 8, e61505 (2013).","journal-title":"PLoS ONE"},{"key":"878_CR73","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/s41596-018-0103-9","volume":"14","author":"J Reimand","year":"2019","unstructured":"Reimand, J. et al. Pathway enrichment analysis and visualization of omics data using g:Profiler, GSEA, Cytoscape and EnrichmentMap. Nat. Protoc. 14, 482\u2013517 (2019).","journal-title":"Nat. Protoc."},{"key":"878_CR74","doi-asserted-by":"publisher","first-page":"11929","DOI":"10.1523\/JNEUROSCI.1860-14.2014","volume":"34","author":"Y Zhang","year":"2014","unstructured":"Zhang, Y. et al. An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J. Neurosci. 34, 11929\u201311947 (2014).","journal-title":"J. Neurosci."},{"key":"878_CR75","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/WAD.0000000000000223","volume":"32","author":"S Weintraub","year":"2018","unstructured":"Weintraub, S. et al. Version 3 of the Alzheimer Disease Centers\u2019 neuropsychological test battery in the uniform data set (UDS). Alzheimer Dis. Assoc. Disord. 32, 10\u201317 (2018).","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"878_CR76","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1002\/alz.13454","volume":"20","author":"R Saloner","year":"2024","unstructured":"Saloner, R. et al. Plasma phosphorylated tau-217 exhibits sex-specific prognostication of cognitive decline and brain atrophy in cognitively unimpaired adults. Alzheimers Dement. 20, 376\u2013387 (2024).","journal-title":"Alzheimers Dement."},{"key":"878_CR77","doi-asserted-by":"publisher","first-page":"3676","DOI":"10.1038\/s41467-024-47971-5","volume":"15","author":"L Karlsson","year":"2024","unstructured":"Karlsson, L. et al. Cerebrospinal fluid reference proteins increase accuracy and interpretability of biomarkers for brain diseases. Nat. Commun. 15, 3676 (2024).","journal-title":"Nat. Commun."},{"key":"878_CR78","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1007\/s00259-022-06065-4","volume":"50","author":"AF Santillo","year":"2023","unstructured":"Santillo, A. F. et al. [18F]RO948 tau positron emission tomography in genetic and sporadic frontotemporal dementia syndromes. Eur. J. Nucl. Med. Mol. Imaging 50, 1371\u20131383 (2023).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"878_CR79","doi-asserted-by":"publisher","first-page":"e1001057","DOI":"10.1371\/journal.pcbi.1001057","volume":"7","author":"P Langfelder","year":"2011","unstructured":"Langfelder, P., Luo, R., Oldham, M. C. & Horvath, S. Is my network module preserved and reproducible? PLoS Comput. Biol. 7, e1001057 (2011).","journal-title":"PLoS Comput. Biol."}],"updated-by":[{"DOI":"10.1038\/s43587-025-00931-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000}}],"container-title":["Nature Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43587-025-00878-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43587-025-00878-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43587-025-00878-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T09:36:27Z","timestamp":1752140187000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43587-025-00878-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,16]]},"references-count":79,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["878"],"URL":"https:\/\/doi.org\/10.1038\/s43587-025-00878-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4103685\/v1","asserted-by":"object"}]},"ISSN":["2662-8465"],"issn-type":[{"value":"2662-8465","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,16]]},"assertion":[{"value":"22 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s43587-025-00931-0","URL":"https:\/\/doi.org\/10.1038\/s43587-025-00931-0","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.M.S. received research support from the NIA\/NIH, the Bluefield Project to Cure FTD, and the Larry L. Hillblom Foundation. He has provided consultation to Alector, Lilly, Passage Bio and Takeda. L.K.F. receives research support from the NIH. O.H. has received research support (for the institution) from AVID Radiopharmaceuticals, Biogen, C2N Diagnostics, Eli Lilly, Eisai, Fujirebio, GE Healthcare and Roche. In the past 2\u2009years, he has received consultancy\/speaker fees from AC Immune, Alzpath, BioArctic, Biogen, Bristol Meyer Squibb, Cerveau, Eisai, Eli Lilly, Fujirebio, Merck, Novartis, Novo Nordisk, Roche, Sanofi and Siemens. J.S.Y. receives research support from the NIH. P.A.L. is a site primary investigator for clinical trials by Alector, AbbVie and Woolsey. He serves as an advisor for Retrotrope. He receives research and salary support from the NIH\u2013NIA and the Alzheimer\u2019s Association-Part the Cloud partnership. E.B. receives research support from the NIH and Lewy Body Dementia Association. B.C.D. is a consultant for Acadia, Alector, Arkuda, Biogen, Denali, Eisai, Genentech, Lilly, Merck, Novartis, Takeda and Wave Lifesciences; receives royalties from Cambridge University Press, Elsevier and Oxford University Press; and receives grant funding from the NIA, the National Institute of Neurological Disorders and Stroke, the National Institute of Mental Health and the Bluefield Foundation. K.D.-R. receives research support from the NIH and serves as an investigator for a clinical trial sponsored by Lawson Health Research Institute. K.F. receives research support from the NIH. N.G. has participated or is currently participating in clinical trials of anti-dementia drugs sponsored by Bristol Myers Squibb, Eli Lilly\/Avid Radiopharmaceuticals, Janssen Immunotherapy, Novartis, Pfizer, Wyeth, SNIFF (The Study of Nasal Insulin to Fight Forgetfulness) and the A4 (The Anti-Amyloid Treatment in Asymptomatic Alzheimer\u2019s Disease) trial; and receives research support from Tau Consortium, the Association for Frontotemporal Dementia and the NIH. N.G.-R. receives royalties from UpToDate and has participated in multicenter therapy studies by sponsored by Biogen, TauRx, and Lilly; and receives research support from the NIH. C.M.H. is a Site PI or SubI for several industry (Alector, Janssen, Biogen, Cogito Tx) sponsored clinical trials with funding through Emory Office of Sponsored Programs. L.S.H. receives research funding from Abbvie, Acumen, Alector, Biogen, BMS, Eisai, Genentech\/Roche, Janssen\/J&J, Transposon, UCB, Vaccinex; and receives consulting fees from Biogen, Cortexyme, Eisai, Medscape, Prevail\/Lilly. G.-Y.R.H. has served as an investigator for clinical trials sponsored by AstraZeneca, Eli Lilly and Roche\/Genentech; and he receives research support from the Canadian Institutes of Health Research and the Alzheimer Society of British Columbia. E.D.H. receives research support from the NIH. J. Kornak has provided expert witness testimony for Teva Pharmaceuticals in\n                      Forest Laboratories Inc.\n                      et al. v\n                      Teva Pharmaceuticals USA, Inc\n                      ., case numbers 1:14-cv-00121 and 1:14-cv-00686 (D. Del. filed 31 January 2014 and 30 May 2014 regarding the drug Memantine) and for Apotex\/HEC\/Ezra in\n                      Novartis AG\n                      et al. v\n                      Apotex Inc\n                      ., case number 1:15-cv-975 (D. Del. filed 26 October 2015 regarding the drug Fingolimod); he has also given testimony on behalf of Puma Biotechnology in\n                      Hsingching Hsu\n                      et al. v\n                      Puma Biotechnology, Inc\n                      ., et al. 2018 regarding the drug neratinib; and he receives research support from the NIH. W.K. receives research funding from AstraZeneca, Biogen, Roche, the Department of Defense and the NIH. M.I.L. receives research support from the NIH. The research of I.L. is supported by the National Institutes of Health grants 2R01AG038791-06A, U01NS100610, U01NS80818, R25NS098999; U19\n                      \n                      -1 and 1R21NS114764-01A1; the Michael J Fox Foundation, Parkinson Foundation, Lewy Body Association, CurePSP, Roche, Abbvie, Biogen, Centogene. EIP-Pharma, Biohaven Pharmaceuticals, Novartis, Brain Neurotherapy Bio and United Biopharma SRL\u2013UCB. She is a scientific advisor for Amydis and Rossy Center for Progressive Supranuclear Palsy University of Toronto. She receives her salary from the University of California San Diego and as Chief Editor of Frontiers in Neurology. C.T.M. receives funding from NIH and Penn Institute on Aging. M.F.M. receives research support from the NIH. A.P. receives research support from the NIH (U01 NS102035; K23\n                      \n                      ). H.L.P. receives research support from the NIH. L.P. receives research support from the NIH. E.M.R. receives research support from the NIH. K.R. receives research support from the NIH. E.D.R. has received research support from the NIH, the Bluefield Project to Cure Frontotemporal Dementia, the Alzheimer\u2019s Association, the Alzheimer\u2019s Drug Discovery Foundation, the BrightFocus Foundation, and Alector; has served as a consultant for AGTC and on a data monitoring committee for Lilly; and owns intellectual property related to tau and progranulin. R.S. receives support from the NIA, the National Institute of Neurological Disorders and Stroke, the Parkinson\u2019s Disease Foundation and Acadia Pharmaceuticals. M.C.T. has served as an investigator for clinical trials sponsored by Biogen, Avanex, Green Valley, Roche\/Genentech, Bristol Myers Squibb, Eli Lilly\/Avid Radiopharmaceuticals and Janssen. She receives research support from the Canadian Institutes of Health Research. B.F.B. has served as an investigator for clinical trials sponsored by Alector, Biogen, Transposon and Cognition Therapeutics. He serves on the Scientific Advisory Board of the Tau Consortium which is funded by the Rainwater Charitable Foundation. He receives research support from NIH. H.J.R. has received research support from Biogen Pharmaceuticals, has consulting agreements with Wave Neuroscience, Ionis Pharmaceuticals, Eisai Pharmaceuticals and Genentech, and receives research support from the NIH and the state of California. J.C.R. receives research support from the NIH and is a site principal investigator for clinical trials sponsored by Eli Lilly and Eisai. A.L.B. receives research support from the NIH, the Tau Research Consortium, the Association for Frontotemporal Degeneration, Bluefield Project to Cure Frontotemporal Dementia, Corticobasal Degeneration Solutions, the Alzheimer\u2019s Drug Discovery Foundation and the Alzheimer\u2019s Association. He has served as a consultant for Aeovian, AGTC, Alector, Arkuda, Arvinas, Boehringer Ingelheim, Denali, GSK, Life Edit, Humana, Oligomerix, Oscotec, Roche, TrueBinding, Wave, Merck and received research support from Biogen, Eisai and Regeneron. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}